A Phase 1 interventional study of MVA-BN in Smallpox, sponsored by Bavarian Nordic. Completed at 1 site in Germany. Open to male participants aged 20 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2005-09-19.
Sponsored by Bavarian Nordic · Phase 1, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies testing MVA-BN smallpox vaccine in Smallpox — none open to participants now, none under way, none of them phase 3. MVA-BN smallpox vaccine · Smallpox.
Among the 16 studies testing MVA-BN smallpox vaccine in Smallpox, this one is the 13th largest by enrollment, is the only one that started in 2001, is one of 3 in phase 1, and was the 4th registered.
73 studies on the registry are indexed under Smallpox; 5 are open to participants now.
Browse Smallpox studies →None of the 16 studies testing MVA-BN smallpox vaccine in Smallpox is open now. The open studies under Smallpox, anywhere →
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 2 Smallpox studies recruiting now, none set no upper age limit and 2 stop at 75 or younger; none take children under 18; 2 take healthy volunteers.
This study: 20 Years to 55 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 12 · Phase 3 1
First in 2001; this study’s year is marked. 1 started in 2001.
This study's enrollment of 90 is below the median of 150 across 61 interventional studies indexed under Smallpox.
Median enrollment 196 across the 16 interventional studies. Of the 16 that completed or were terminated, 11 (69%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 16 have an industry lead sponsor. The 3 most frequent:
Bavarian Nordic is the lead sponsor of 58 studies on the registry; 2 are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 12 (75%) have results posted.
11 studies in Smallpox by Bavarian Nordic: none open now, none under way, none of them phase 3. Of 11 finished, 8 (73%) have results posted.
Among the 11 studies in Smallpox by Bavarian Nordic, this one is the 9th largest by enrollment, is the only one that started in 2001, is one of 2 in phase 1, and was the 2nd registered.
Bavarian Nordic’s Smallpox studies by the year they started, since 2001.
None of the studies under way reaches primary completion within a year.
Among the 16 studies testing MVA-BN smallpox vaccine in Smallpox, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Bavarian Nordic’s 11 in Smallpox:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to collect information on the safety, tolerability and immunogenicity of an investigational smallpox vaccine at different doses and using different routes of administration in vaccinia-naive and vaccinated healthy volunteers
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The record gives a start of Apr 2001 and a completion of Jul 2003. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2005. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: MVA-BN smallpox vaccine